HCPCS Level II
J9045
Injection, carboplatin, 50 mg
Codes near J9045
These sit next to J9045 in the CMS Level II file. All J codes
- J9040Injection, bleomycin sulfate, 15 units
- J9041Injection, bortezomib, 0.1 mg
- J9042Injection, brentuximab vedotin, 1 mg
- J9043Injection, cabazitaxel, 1 mg
- J9044Injection, bortezomib, not otherwise specified, 0.1 mg
- J9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
- J9047Injection, carfilzomib, 1 mg
- J9048Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
- J9049Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
- J9050Injection, carmustine, 100 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00703-4239-01 | Carboplatin | Teva Parenteral Medicines, Inc. | 12 |
| 00703-4239-81 | Carboplatin | Teva Parenteral Medicines, Inc. | 12 |
| 00703-4244-01 | Carboplatin | Teva Parenteral Medicines, Inc. | 1 |
| 00703-4244-81 | Carboplatin | Teva Parenteral Medicines, Inc. | 1 |
| 00703-4246-01 | Carboplatin | Teva Parenteral Medicines, Inc. | 3 |
| 00703-4246-81 | Carboplatin | Teva Parenteral Medicines, Inc. | 3 |
| 00703-4248-01 | Carboplatin | Teva Parenteral Medicines, Inc. | 9 |
| 00703-4248-81 | Carboplatin | Teva Parenteral Medicines, Inc. | 9 |
| 16729-0295-12 | Carboplatin | Accord Healthcare Inc | 12 |
| 16729-0295-34 | Carboplatin | Accord Healthcare Inc | 9 |
| 55150-0335-00 | Carboplatin | Eugia US LLC | 9 |
| 55150-0335-01 | Carboplatin | Eugia US LLC | 9 |
| 55150-0386-00 | Carboplatin | Eugia US LLC | 12 |
| 55150-0386-01 | Carboplatin | Eugia US LLC | 12 |
| 60505-6282-01 | Carboplatin | Apotex Corp | 1 |
| 60505-6282-03 | Carboplatin | Apotex Corp | 3 |
| 60505-6282-06 | Carboplatin | Apotex Corp | 9 |
| 60505-6282-07 | Carboplatin | Apotex Corp | 12 |
| 61703-0150-05 | Carboplatin | Pfizer Inc | 3 |
| 61703-0262-05 | Carboplatin | Pfizer Inc | 9 |
| 61703-0339-18 | Carboplatin | Pfizer Inc | 1 |
| 61703-0339-22 | Carboplatin | Pfizer Inc | 3 |
| 61703-0339-50 | Carboplatin | Pfizer Inc | 9 |
| 61703-0339-56 | Carboplatin | Pfizer Inc | 12 |
| 61703-0360-18 | Carboplatin | Pfizer Inc | 1 |
| 61703-0600-05 | Carboplatin | Pfizer Inc | 12 |
| 63323-0172-60 | Carboplatin | FreseniUS Kabi USA, LLC | 12 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.